InnAVasc Medical, Inc. is a medical device company founded by Duke University surgeons and scientists, which designs and develops products for vascular access for hemodialysis. The Company’s first technology is an arteriovenous graft (AVG) modification that incorporates two cannulation Pods, with low bleed technology, that are resistant to posterior and sidewall needle penetration and injury. The InnAVasc arteriovenous graft was designed to reduce the potential for adverse events and device failures associated with repeated vascular access.